1SchiUinger JA, Dunne EF, Chapin JB, et al. Prevalence of Chlamydia trachomatis infection among men screened in 4 U.S. cities. Sex Transm Dis, 2005, 32(2): 74-77.
2Parish WL, Laumann EO, Cohen MS, et al. Population-based study of chlamydial infection in China: a hidden epidemic. JAMA, 2003, 289( 10): 1265-1273.
3Dessus-Babus S, Bebear CM, Charron A, et al. Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained In vitro. Antimicrob Agents Chemother, 1998, 42 ( 10): 2474-2481.
4Kniaz'kin IV, Aleksandrov VP, Zeziulin PN, et al. Use of avelox in treating urogenital infections in men. Urologiia, 2002, (5): 6-8.,
5Somani J, Bhullar VB, Workowski KA, et al. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis, 2000, 181(4): 1421-1427.
7SCHILLINGER JA, DUNNE EF, CHAPIN JB, et al. Prevalence of Chlamydia trachomatis infection among men screened in 4 U. S. cities[J]. Sex Transm Dis, 2005, 32(2): 74-77.
8PARISH WL, LAUMANN EO, COHEN MS, et al. Popula- tion-based study of chlamydial infection in China: a hidden epidemic[J]. JAMA, 2003, 289(10): 1265-1273.
9SOMANI J, BHULLAR VB, WORKOWSKI KA, et al. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure[J]. J Infect Dis, 2000, 181(4): 1421-1427.
10CHE YM, ZHENG HY, LIU Qz, et al. The muhi-eenter clinical observation of minocycline in the treatment of non-gonocoecal urethritis (cervical) inflanlmation[J]. Journal of Clinical Dermatolo- gy, 2007, 36(4): 262.
